Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Moodys
Medtronic
Merck
AstraZeneca

Last Updated: November 27, 2022

Mylan Labs Company Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the competitive landscape for MYLAN LABS, and what generic and branded alternatives to MYLAN LABS drugs are available?

MYLAN LABS has one hundred and forty-eight approved drugs.

There are fourteen tentative approvals on MYLAN LABS drugs.

Summary for Mylan Labs
US Patents:0
Tradenames:101
Ingredients:93
NDAs:148

Drugs and US Patents for Mylan Labs

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Labs Ltd GEMCITABINE HYDROCHLORIDE gemcitabine hydrochloride INJECTABLE;INJECTION 205242-003 Dec 6, 2017 AP RX No No See Plans and Pricing See Plans and Pricing
Mylan Labs Ltd CARBOPLATIN carboplatin INJECTABLE;INTRAVENOUS 091063-001 Nov 9, 2011 DISCN No No See Plans and Pricing See Plans and Pricing
Mylan Labs Ltd OXALIPLATIN oxaliplatin INJECTABLE;INTRAVENOUS 091358-003 Nov 14, 2017 DISCN No No See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Baxter
Johnson and Johnson
Merck
Mallinckrodt
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.